Nexus NeuroTech Ventures

San Francisco, United States Founded: 2023 • Age: 3 yrs
Investments are focused on neurotechnology for brain disorders.

About Nexus NeuroTech Ventures

Nexus NeuroTech Ventures is a Healthcare company based in San Francisco (United States) founded in 2023. Investments are focused on neurotechnology for brain disorders. It operates on a HealthTech model. Nexus NeuroTech Ventures offers products and services including Neurotechnology Investments. Its focus areas include Medical Technology and Neurotechnology.

Company details

Nexus NeuroTech Ventures is dedicated to supporting breakthrough technologies for brain disorders. Investments are made in solutions addressing neurodegenerative, neuropsychiatric, and neurodevelopmental conditions such as Parkinsons disease, bipolar disorder, and autism spectrum disorder. The portfolio is built to include diagnostic and management technologies, spanning less invasive to more invasive medical interventions, software- and hardware-based diagnostics, data platforms for clinical trials, and tools for clinical research and care. A holistic approach is adopted to tackle brain disorders through innovative healthcare solutions.

  • Headquarters San Francisco, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website nexusneurotech.com
  • Social LinkedIn
Operational Areas

Products & Services of Nexus NeuroTech Ventures

Nexus NeuroTech Ventures offers a comprehensive portfolio of products and services, including Neurotechnology Investments.

Neurotechnology Investments
Investment Services

Investments are made in neurotechnology for brain disorders.

Top companies in Neurology

3 companies that operate in the same segment as Nexus NeuroTech Ventures (Neurology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nexus NeuroTech Ventures

Nexus NeuroTech Ventures was founded in 2023.

Nexus NeuroTech Ventures is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Nexus NeuroTech Ventures is dedicated to supporting breakthrough technologies for brain disorders. Investments are made in solutions addressing neurodegenerative, neuropsychiatric, and neurodevelopmental conditions such as Parkinsons disease, bipolar disorder, and autism spectrum disorder. The portfolio is built to include diagnostic and management technologies, spanning less invasive to more invasive medical interventions, software- and hardware-based diagnostics, data platforms for clinical trials, and tools for clinical research and care. A holistic approach is adopted to tackle brain disorders through innovative healthcare solutions.

Nexus NeuroTech Ventures offers Neurotechnology Investments.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available